No Data
No Data
ImmunoPrecise Antibodies Announces Its Support For FDA's Recent Decision To Phase Out Animal Testing Requirements For Monoclonal Antibodies And Other Pharmaceutical Products
Benchmark Co. Maintains ImmunoPrecise Antibodies(IPA.US) With Buy Rating, Maintains Target Price $3
ImmunoPrecise Antibodies Analyst Ratings
Express News | Immunoprecise Antibodies Ltd. : H.c. Wainwright Cuts Target Price to $5 From $7
Earnings Call Summary | ImmunoPrecise Antibodies(IPA.US) Q3 2025 Earnings Conference
ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)